Patents by Inventor Teresa Lynn Burgess

Teresa Lynn Burgess has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain
    Patent number: 8617831
    Abstract: Methods for measuring c-Met levels in urine and blood samples are provided. Methods for diagnosis and prognosis evaluation for cancer are also provided.
    Type: Grant
    Filed: September 26, 2012
    Date of Patent: December 31, 2013
    Assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Amgen, Inc.
    Inventors: Donald P. Bottaro, Gagani P. Athauda, Teresa Lynn Burgess
  • METHODS FOR DIAGNOSING AND MONITORING THE PROGRESSION OF CANCER
    Publication number: 20130029352
    Abstract: Methods for measuring c-Met levels in urine and blood samples are provided. Methods for diagnosis and prognosis evaluation for cancer are also provided.
    Type: Application
    Filed: September 26, 2012
    Publication date: January 31, 2013
    Inventors: Donald P. Bottaro, Gagani P. Athauda, Teresa Lynn Burgess
  • Methods for diagnosing and monitoring the progression of cancer by measuring soluble c-Met ectodomain
    Patent number: 8304199
    Abstract: Methods for measuring c-Met levels in urine and blood samples are provided. Methods for diagnosis and prognosis evaluation for cancer are also provided.
    Type: Grant
    Filed: March 22, 2011
    Date of Patent: November 6, 2012
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, Amgen, Inc.
    Inventors: Donald P. Bottaro, Gagani Athauda, Teresa Lynn Burgess
  • Methods For Diagnosing And Monitoring The Progression Of Cancer
    Publication number: 20110287450
    Abstract: Methods for measuring c-Met levels in urine and blood samples are provided. Methods for diagnosis and prognosis evaluation for cancer are also provided.
    Type: Application
    Filed: March 22, 2011
    Publication date: November 24, 2011
    Applicants: Amgen, Inc., The United States of America, as represented by the Secretary, Dept. of Health & Human Service
    Inventors: Donald P. Bottaro, Gagani Athauda, Teresa Lynn Burgess
  • Methods for diagnosing and monitoring the progression of cancer
    Patent number: 7964365
    Abstract: Methods for measuring c-Met levels in urine and blood samples are provided. Methods for diagnosis and prognosis evaluation for cancer are also provided.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: June 21, 2011
    Assignees: The United States of Americam as represented by the Secretary, Department of Health and Human Services, Amgen, Inc.
    Inventors: Donald P. Bottaro, Gagani Athauda, Teresa Lynn Burgess
  • Methods for Diagnosing and Monitoring the Progression of Cancer
    Publication number: 20080286825
    Abstract: Methods for measuring c-Met levels in urine and blood samples are provided. Methods for diagnosis and prognosis evaluation for cancer are also provided.
    Type: Application
    Filed: November 8, 2006
    Publication date: November 20, 2008
    Inventors: Donald P. Bottaro, Gagani P. Athauda, Teresa Lynn Burgess